跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确将半监督方法扩展至平均治疗效应估计及因果结论的推广与迁移。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Facheng Yu
Zhen Qi
Yuqian Zhang

利用无标签汇总统计量的半监督推断

研究问题
当无标签样本只能提供均值与协方差等汇总信息时,如何改善均值估计、纠正标签选择偏差,并推广平均治疗效应?
方法与思路
作者构造仅对有标签数据进行样本分割的交叉拟合方法,分别处理标签与协变量独立或相关的情形,并扩展至治疗效应估计。
材料陈述的贡献
摘要称,无标签汇总量仍可改善效率与选择偏差,方法适用于高维并对模型误设稳健,且在相应稀疏条件下支持有效推断。
阅读关注点
应核对汇总量需要包含哪些信息、标签选择与总体差异的条件,以及交叉拟合、稀疏限制和治疗效应迁移的识别依据。
阅读边界
这是arXiv预印本,同行评审或期刊接收未经核实。摘要未说明具体稀疏率、汇总量精度要求或稳健性与可迁移性的边界。

原文摘要

Semi-supervised inference assumes access to a labeled dataset together with a large unlabeled dataset in which the outcome variable is missing, and it is widely used to improve statistical efficiency and support generalizability across populations. In many modern applications, however, individual-level unlabeled data may not be directly accessible due to privacy restrictions, data-sharing limits, or storage constraints, while summary statistics such as sample means and covariances from the unlabeled population are often available. In this work, we study this constrained semi-supervised setting where, in addition to labeled data with individualized observations, auxiliary information from the unlabeled population is available only through summary statistics. We propose new semi-supervised inference methods for mean estimation under both covariate-independent and covariate-dependent labeling and show that unlabeled summaries can still improve efficiency and help correct selection bias. The proposed methods apply in high dimensions and are robust to model misspecification. Valid inference is obtained under sparsity conditions comparable to those required by semi-supervised methods that assume access to individual-level unlabeled samples. Our approach relies on a specialized cross-fitting procedure, where sample splitting is applied only to the labeled data, which removes the need for individualized unlabeled covariates. We further extend this framework to average treatment effect estimation, enabling generalizability and transportability of causal conclusions in this constrained semi-supervised setting.

笔记与分组
相关领域论文